122 related articles for article (PubMed ID: 9399947)
1. Immunization against the agent of human granulocytic ehrlichiosis in a murine model.
Sun W; IJdo JW; Telford SR; Hodzic E; Zhang Y; Barthold SW; Fikrig E
J Clin Invest; 1997 Dec; 100(12):3014-8. PubMed ID: 9399947
[TBL] [Abstract][Full Text] [Related]
2. Granulocytic ehrlichiosis in tick-immune guinea pigs.
Das S; Deponte K; Marcantonio NL; Ijdo JW; Hodzic E; Katavolos P; Barthold SW; Telford SR; Kantor FS; Fikrig E
Infect Immun; 1998 Apr; 66(4):1803-5. PubMed ID: 9529119
[TBL] [Abstract][Full Text] [Related]
3. Gamma interferon dominates the murine cytokine response to the agent of human granulocytic ehrlichiosis and helps to control the degree of early rickettsemia.
Akkoyunlu M; Fikrig E
Infect Immun; 2000 Apr; 68(4):1827-33. PubMed ID: 10722570
[TBL] [Abstract][Full Text] [Related]
4. Characterization of monoclonal antibodies to the 44-kilodalton major outer membrane protein of the human granulocytic ehrlichiosis agent.
Kim HY; Rikihisa Y
J Clin Microbiol; 1998 Nov; 36(11):3278-84. PubMed ID: 9774579
[TBL] [Abstract][Full Text] [Related]
5. Cloning of the gene encoding the 44-kilodalton antigen of the agent of human granulocytic ehrlichiosis and characterization of the humoral response.
Ijdo JW; Sun W; Zhang Y; Magnarelli LA; Fikrig E
Infect Immun; 1998 Jul; 66(7):3264-9. PubMed ID: 9632594
[TBL] [Abstract][Full Text] [Related]
6. Infection of mice with the agent of human granulocytic ehrlichiosis after different routes of inoculation.
Hodzic E; Feng S; Fish D; Leutenegger CM; Freet KJ; Barthold SW
J Infect Dis; 2001 Jun; 183(12):1781-6. PubMed ID: 11372031
[TBL] [Abstract][Full Text] [Related]
7. Transmission of the agent of human granulocytic ehrlichiosis by Ixodes spinipalpis ticks: evidence of an enzootic cycle of dual infection with Borrelia burgdorferi in Northern Colorado.
Zeidner NS; Burkot TR; Massung R; Nicholson WL; Dolan MC; Rutherford JS; Biggerstaff BJ; Maupin GO
J Infect Dis; 2000 Aug; 182(2):616-9. PubMed ID: 10915099
[TBL] [Abstract][Full Text] [Related]
8. The early humoral response in human granulocytic ehrlichiosis.
IJdo JW; Zhang Y; Hodzic E; Magnarelli LA; Wilson ML; Telford SR; Barthold SW; Fikrig E
J Infect Dis; 1997 Sep; 176(3):687-92. PubMed ID: 9291316
[TBL] [Abstract][Full Text] [Related]
9. Acquisition dynamics of Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis at the host-vector interface.
Hodzic E; Borjesson DL; Feng S; Barthold SW
Vector Borne Zoonotic Dis; 2001; 1(2):149-58. PubMed ID: 12680352
[TBL] [Abstract][Full Text] [Related]
10. Coinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis suppresses IL-2 and IFN gamma production and promotes an IL-4 response in C3H/HeJ mice.
Zeidner NS; Dolan MC; Massung R; Piesman J; Fish D
Parasite Immunol; 2000 Nov; 22(11):581-8. PubMed ID: 11116438
[TBL] [Abstract][Full Text] [Related]
11. Development and distribution of pathologic lesions are related to immune status and tissue deposition of human granulocytic ehrlichiosis agent-infected cells in a murine model system.
Bunnell JE; Trigiani ER; Srinivas SR; Dumler JS
J Infect Dis; 1999 Aug; 180(2):546-50. PubMed ID: 10395880
[TBL] [Abstract][Full Text] [Related]
12. Human granulocytic ehrlichiosis presenting as facial diplegia in a 42-year-old woman.
Lee FS; Chu FK; Tackley M; Wu AD; Atri A; Wessels MR
Clin Infect Dis; 2000 Nov; 31(5):1288-91. PubMed ID: 11073767
[TBL] [Abstract][Full Text] [Related]
13. Cutting edge: infection by the agent of human granulocytic ehrlichiosis prevents the respiratory burst by down-regulating gp91phox.
Banerjee R; Anguita J; Roos D; Fikrig E
J Immunol; 2000 Apr; 164(8):3946-9. PubMed ID: 10754283
[TBL] [Abstract][Full Text] [Related]
14. Granulocytic ehrlichiosis in the laboratory mouse.
Hodzic E; Ijdo JW; Feng S; Katavolos P; Sun W; Maretzki CH; Fish D; Fikrig E; Telford SR; Barthold SW
J Infect Dis; 1998 Mar; 177(3):737-45. PubMed ID: 9498456
[TBL] [Abstract][Full Text] [Related]
15. Isolation of the etiologic agent of human granulocytic ehrlichiosis from the white-footed mouse (Peromyscus leucopus).
Ravyn MD; Kodner CB; Carter SE; Jarnefeld JL; Johnson RC
J Clin Microbiol; 2001 Jan; 39(1):335-8. PubMed ID: 11136794
[TBL] [Abstract][Full Text] [Related]
16. Monocytic differentiation inhibits infection and granulocytic differentiation potentiates infection by the agent of human granulocytic ehrlichiosis.
Klein MB; Hayes SF; Goodman JL
Infect Immun; 1998 Jul; 66(7):3410-5. PubMed ID: 9632613
[TBL] [Abstract][Full Text] [Related]
17. [Serologic and clinical evidence for endemic occurrences of human granulocytic ehrlichiosis in North-Eastern Switzerland].
Weber R; Pusterla N; Loy M; Leutenegger CM; Schär G; Baumann D; Wolfensberger C; Lutz H
Schweiz Med Wochenschr; 2000 Oct; 130(41):1462-70. PubMed ID: 11075410
[TBL] [Abstract][Full Text] [Related]
18. Exploitation of interleukin-8-induced neutrophil chemotaxis by the agent of human granulocytic ehrlichiosis.
Akkoyunlu M; Malawista SE; Anguita J; Fikrig E
Infect Immun; 2001 Sep; 69(9):5577-88. PubMed ID: 11500432
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of CD11b/CD18 up-regulation during infection with the agent of human granulocytic ehrlichiosis in mice.
Borjesson DL; Simon SI; Hodzic E; Ballantyne CM; Barthold SW
Lab Invest; 2002 Mar; 82(3):303-11. PubMed ID: 11896209
[TBL] [Abstract][Full Text] [Related]
20. Characterization of an immunoreactive protein from the agent of human granulocytic ehrlichiosis.
Kolbert CP; Bruinsma ES; Abdulkarim AS; Hofmeister EK; Tompkins RB; Telford SR; Mitchell PD; Adams-Stich J; Persing DH
J Clin Microbiol; 1997 May; 35(5):1172-8. PubMed ID: 9114402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
